Medicare Reimbursement Announced For Third Dose Of COVID-19 Vaccine For Immunocompromised Individuals

The U.S. Food and Drug Administration (FDA) amended the emergency use authorizations for both the Pfizer-BioNTech and the Moderna COVID-19 vaccines to allow for the use of an additional dose in certain immunocompromised individuals, especially solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise on August 12, 2021. 

Get In Touch!
close slider

    Get In Touch!